Patent 12007397 was granted and assigned to PrognomiQ on June, 2024 by the United States Patent and Trademark Office.
Described herein are methods for screening for a disease state. The method may include obtaining multiple data sets, and identifying the disease state based on a combination of the data sets. The data sets may include biomolecule measurements obtained by multiple methods, such as through the use of particles and reference biomolecules.